OraSure Technologies | OSUR - Interest Expense On Debt


OraSure Technologies reported 1.67M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Agilent USD 29M 4M Jun/2026
AngioDynamics USD 102K 2K Sep/2025
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Bio Techne USD 3.6M 1.19M Jun/2026
Bio-Rad Laboratories USD 12.1M 200K Jun/2026
Bruker USD 17.8M 9.7M Jun/2026
Cerus USD 2.33M 96K Jun/2024
Charles River Laboratories USD 30.34M 3.6M Jun/2026
Danaher USD 107M 44M Jun/2026
Dentsply International USD 22M 2M Jun/2026
Dexcom USD 3.1M 1.1M Mar/2026
Illumina USD 24M 2M Mar/2026
Integra LifeSciences USD 22.99M 529K Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
IQVIA Holdings USD 197M 5M Jun/2026
Mesa Laboratories USD 3.02M 180K Sep/2024
Mettler Toledo International USD 17.25M 239K Jun/2026
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Quidel USD 5.63B 5.58B Mar/2026
Repligen USD 5.66M 85K Jun/2026
Revvity USD 22.99M 1.73M Jun/2026
STAAR Surgical USD 800K 799K Sep/2025
Thermo Fisher Scientific USD 354M 11M Mar/2026
Trinity Biotech USD 3.33M 50K Sep/2025
Waters USD 55M 13M Jun/2026